Cargando…
Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment
Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy with an annual incidence of ~1 case per million population. Differentiating between ACC and benign adrenocortical tumors can be challenging in patients who present with an incidentally discovered adrenal mass, due to the limited specifi...
Autores principales: | Shariq, Omair A., McKenzie, Travis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295938/ https://www.ncbi.nlm.nih.gov/pubmed/34349894 http://dx.doi.org/10.1177/20406223211033103 |
Ejemplares similares
-
Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)
por: Jang, Eunju, et al.
Publicado: (2021) -
Advancements in the treatment of differentiated thyroid
cancer
por: Stewart, Latoya A., et al.
Publicado: (2021) -
Medullary thyroid carcinoma: recent advances in identification,
treatment, and prognosis
por: Bartz-Kurycki, Marisa A., et al.
Publicado: (2021) -
Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology
por: Agosto Salgado, Sarimar
Publicado: (2021) -
Advances in the diagnosis and the management of primary hyperparathyroidism
por: Islam, Ana Kashfia
Publicado: (2021)